1. Webb NR, Jesse MK. Hip pain. Bisphosphonate-related atypical subtrochanteric femoral fracture in patient with Paget disease. Skeletal Radiol. 2016; 45:825–826. 853–854.
2. Rosen CJ, Compston JE, Lian JB, editors. Primer on the metabolic bone diseases and disorders of mineral metabolism. 7th ed. Washington, DC: American Society for Bone and Mineral Research;2008.
3. Galson DL, Roodman GD. Pathobiology of paget's disease of bone. J Bone Metab. 2014; 21:85–98.
Article
4. Chung YG, Kang YK, Rhee SK, et al. Skeletal manifestation of Paget's disease in Korean. J Korean Orthop Assoc. 2002; 37:649–653.
Article
5. Bhargava P, Maki JH. Images in clinical medicine. “Cotton wool” appearance of Paget's disease. N Engl J Med. 2010; 363:e9.
6. Khosla S, Burr D, Cauley J, et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2007; 22:1479–1491.
Article
7. Park YC, Song HK, Zheng XL, et al. Intramedullary nailing for atypical femoral fracture with excessive anterolateral bowing. J Bone Joint Surg Am. 2017; 99:726–735.
Article
8. Koh JS, Goh SK, Png MA, et al. Femoral cortical stress lesions in long-term bisphosphonate therapy: a herald of impending fracture? J Orthop Trauma. 2010; 24:75–81.
Article
9. Tan A, Goodman K, Walker A, et al. Long-term randomized trial of intensive versus symptomatic management in Paget's disease of bone: The PRISM-EZ study. J Bone Miner Res. 2017; DOI:
10.1002/jbmr.3066.
Article
10. Yang KH, Min BW, Ha YC. Atypical femoral fracture: 2015 position statement of the Korean society for bone and mineral research. J Bone Metab. 2015; 22:87–91.
Article
11. Won Y, Lim JR, Kim YH, et al. Atypical femoral fracture combined with osteonecrosis of jaw during osteoporosis treatment with bisphosphonate. J Bone Metab. 2014; 21:155–159.
Article
12. Oh Y, Wakabayashi Y, Kurosa Y, et al. Stress fracture of the bowed femoral shaft is another cause of atypical femoral fracture in elderly Japanese: a case series. J Orthop Sci. 2014; 19:579–586.
Article
13. Shane E, Burr D, Abrahamsen B, et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2014; 29:1–23.
Article
14. Cho JW, Oh CW, Leung F, et al. Healing of atypical subtrochanteric femur fractures after cephalomedullary nailing: which factors predict union? J Orthop Trauma. 2017; 31:138–145.
Article
15. Lim HS, Kim CK, Park YS, et al. Factors associated with increased healing time in complete femoral fractures after long-term bisphosphonate therapy. J Bone Joint Surg Am. 2016; 98:1978–1987.
Article
16. Reid IR, Sharma S, Kalluru R, et al. Treatment of Paget's disease of bone with denosumab: case report and literature review. Calcif Tissue Int. 2016; 99:322–325.
Article
17. Sun LM, Lin MC, Muo CH, et al. Calcitonin nasal spray and increased cancer risk: a population-based nested case-control study. J Clin Endocrinol Metab. 2014; 99:4259–4264.
Article
18. Wells G, Chernoff J, Gilligan JP, et al. Does salmon calcitonin cause cancer? A review and meta-analysis. Osteoporos Int. 2016; 27:13–19.
Article